What top creators are saying about ArriVent BioPharma, Inc.(AVBP)
Biotechnology company developing therapies for cancer and other diseases
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about ArriVent BioPharma, Inc..
Top creators covering ArriVent BioPharma, Inc. (AVBP)
The 1 sources with the most insights about ArriVent BioPharma, Inc. on Kazuha.
Latest insights about ArriVent BioPharma, Inc. (AVBP)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
A Phase 3 study narrowly missed its endpoint with a p-value of 0.06, described as a significant setback.
Yesterday
A Phase 3 study narrowly missed its endpoint with a p-value of 0.06, described as a significant setback.
Discussed alongside ArriVent BioPharma, Inc. (AVBP)
Other assets that creators frequently mention in the same content as ArriVent BioPharma, Inc..
Frequently asked
Which podcasters and creators cover ArriVent BioPharma, Inc. (AVBP) the most?
The most active sources covering ArriVent BioPharma, Inc. (AVBP) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about ArriVent BioPharma, Inc. (AVBP) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about ArriVent BioPharma, Inc. (AVBP) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside ArriVent BioPharma, Inc. (AVBP)?
Creators covering ArriVent BioPharma, Inc. (AVBP) most frequently also discuss 000660.KS, AAOI, DNA, INTC, AMD. See the "Discussed alongside" section above for full asset pages.